中心性浆液性脉络膜视网膜病变的临床研究与治疗评价  

Clinical research and evaluation of central serous chorioretinopathy

作　　者：唐风雷[1] 朱珊梅[1] 周建强[2] 于忠兴[3] 朱太春[2] 谢秀雯[2] 蒋星[1] 陆人杰[1] 

机构地区：[1]常州市第三人民医院药事科,江苏省常州市213000 [2]常州市第三人民医院眼科,江苏省常州市213000 [3]常州市第三人民医院办公室,江苏省常州市213000

出　　处：《眼科新进展》2013年第11期1089-1093,共5页Recent Advances in Ophthalmology

基　　金：常州四药临床药学科研基金项目(编号:CY20119023)~~

摘　　要：中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)发病与视网膜色素上皮结构缺陷、血管脆性和脉络膜瘀血等病理机制有关。眼底荧光血管造影、吲哚青绿血管造影和光学相干断层扫描等可以辅助诊断本病。复发性或慢性CSC治疗困难,并可能导致永久的视力丧失,但目前可以运用激光光凝、光动力疗法和玻璃体内注射抗血管内皮生长因子等手段进行治疗。本文将综述CSC病理、诊断、治疗等要点和尚未解决的主要问题。Several mechanisms may play a role in the development of central se- rous chorioretinopathy （CSC）, including structural retinal pigment epithelium defects, vascular fragility and choroidal stasis. The diagnosis can be confirmed by fundus fluorescein angiography,indocyanine green angiography and optical coherence tomography. Although recurrent and chronic CSC are often difficult to treat and can lead to permanent vision loss, laser photocoagulation, photodynamic dynamic therapy and anti-vascu- lar endothelial growth factor intravitreal injections treatment can be used. This article reviews the pathogenesis, diagnosis, treatment and major unresolved issues related to CSC.

关 键 词：中心性浆液性脉络膜视网膜病变 视网膜浆液性脱离 视网膜色素上皮细胞 

分 类 号：R774.1[医药卫生—眼科]